NRSN (NeuroSense Therapeutics) Dividends Received


NRSN NeuroSense Therapeutics Ltd NRSN
31 GF Score
Price $0.72
! 2 Warning Signs
View Full Analysis

What is NeuroSense Therapeutics Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

NRSN
31GF Score
NeuroSense Therapeutics Ltd NRSN
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NeuroSense Therapeutics Business Description

Other Exchanges H1Z:Germany
Address 11 HaMenofim Street, Building B, Herzliya, ISR, 4672562
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
31GF Score

Get the complete analysis for NRSN

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.72
Price